In a testament to resilience and the human spirit’s capacity to defy limitations, Bertrand Cita—a man diagnosed with a progressive myopathy twelve years ago—has embarked on an extraordinary 1,300-kilometer cycling journey across France. His mission? To challenge perceptions of disability, prove that determination can overcome physical constraints, and inspire others facing similar battles. Departing from an undisclosed starting point on Friday, May 22, 2026, Cita’s cross-country expedition is not merely a physical feat but a bold statement: that chronic illness need not dictate one’s ability to live fully and pursue ambitious goals.
Myopathies—a diverse group of muscular disorders characterized by progressive weakness and degeneration of the skeletal muscles—often carry profound physical and emotional tolls. For Cita, the diagnosis arrived twelve years ago, marking the beginning of a journey that has since been defined by both adversity and extraordinary perseverance. While myopathies are typically not classified as autoimmune diseases (a distinction rooted in their primary mechanism of muscle fiber damage rather than immune system misfiring), Cita’s specific condition may involve inflammatory or metabolic pathways that warrant further medical clarification. The French cycling adventure, now in its third day, has already drawn attention as a rare public-facing narrative of how individuals with chronic conditions can redefine their relationship with their bodies and society.
Accompanied by his partner, Roseline, and supported by a support team including Éric in a support vehicle, Cita’s route has taken him through regions including Brittany, where he was spotted in Pontivy on Sunday, May 24. The choice of cycling—a low-impact yet physically demanding activity—as the medium for his advocacy reflects a deliberate strategy to demonstrate adaptability. “If she [the disease] wins, she wins,” Cita has shared in interviews, “but without regrets, by seizing life with both hands.” His philosophy resonates deeply in a global context where chronic illness affects millions, yet societal narratives often focus on limitations rather than potential.
From Diagnosis to Defiance: Understanding Myopathy and Its Impact
Myopathies encompass over 30 distinct disorders, each with unique genetic, metabolic, or structural causes. While some forms are congenital, others—like inflammatory myopathies—can emerge later in life due to autoimmune responses or environmental triggers. Cita’s case, though not explicitly detailed in verified sources, aligns with broader trends where individuals with myopathies increasingly advocate for visibility and accessibility. The Association Française contre les Myopathies (AFM Téléthon), France’s leading nonprofit dedicated to myopathy research and patient support, reports that approximately 1 in 1,000 people worldwide live with some form of the condition. Symptoms range from muscle weakness and fatigue to respiratory and cardiac complications, with treatments focusing on symptom management, physical therapy, and, in some cases, experimental therapies.
What sets Cita’s story apart is his proactive approach to reclaiming agency. Rather than retreating into the margins of illness, he has chosen to traverse France—a country renowned for its cycling culture—on a route that mirrors the endurance required to navigate chronic conditions. His journey is not just physical but symbolic: a challenge to the passive narratives often assigned to disability. “The goal is to show that everything is possible,” he has stated, emphasizing that myopathy does not equate to incapacity. This message holds particular weight in France, where advocacy for disability rights and inclusive sports has gained momentum in recent years.
Why This Journey Matters: Breaking Barriers in Chronic Illness Advocacy
Cita’s expedition intersects with a broader cultural shift toward visibility in chronic illness communities. High-profile campaigns, such as those led by athletes with disabilities or public figures sharing their health journeys, have increasingly highlighted the need for representation. In France, initiatives like the Sport-Santé program, which promotes adaptive sports for individuals with disabilities, reflect this growing awareness. Cita’s project, however, stands out for its individuality and immediacy: a solo, real-time demonstration of what is achievable despite physical constraints.
For readers grappling with chronic conditions—or those seeking to support loved ones—the story offers a reminder that resilience is not synonymous with the absence of struggle. Cita’s journey underscores the importance of adaptive strategies, community support, and the power of narrative in reshaping societal perceptions. “Croquer la vie à pleines dents” (“seizing life with teeth”) encapsulates his ethos: a refusal to let illness dictate one’s horizon.
Logistics and Next Steps: Tracking Cita’s Progress
As of May 25, 2026, Cita remains on track to complete his 1,300-kilometer route by early June, with his progress documented through social media and local press coverage. While exact daily milestones are not yet confirmed, his team has indicated that the journey will conclude in the south of France, potentially in regions like Provence or the French Riviera. Updates are expected to be shared via verified channels, including the AFM Téléthon’s official communications.
For those interested in following Cita’s adventure or supporting myopathy research, the following resources provide further information:
- Association Française contre les Myopathies (AFM Téléthon): Offers resources, research updates, and patient support.
- Muscular Dystrophy News: Global news and research on myopathies and related conditions.
- Sport-Santé France: Promotes adaptive sports and physical activity for individuals with disabilities.
Key Takeaways: Lessons from Cita’s Journey
- Resilience as a Spectrum: Chronic illness does not preclude ambition. Cita’s journey demonstrates that adaptive strategies—such as choosing low-impact activities like cycling—can turn physical challenges into opportunities for growth.
- The Power of Visibility: Public narratives about disability can dismantle stigma. Cita’s expedition serves as a case study in how individual stories can inspire systemic change in healthcare and accessibility.
- Community Support: The role of partners, support teams, and advocacy organizations (like AFM Téléthon) is critical in enabling such endeavors. Cita’s success is as much a testament to his determination as it is to the networks that sustain him.
- Redefining “Possible”: Societal perceptions of disability often underestimate potential. Cita’s journey challenges these assumptions by proving that with the right mindset and resources, limitations can be transcended.
What’s Next for Bertrand Cita?
While Cita’s immediate goal is to complete his 1,300-kilometer journey, his long-term aspirations remain focused on advocacy. Post-expedition, he is expected to share his experiences through public talks, media interviews, and potential collaborations with organizations like AFM Téléthon. His story may also catalyze discussions around adaptive sports, workplace accessibility, and the need for greater representation of chronic illness in mainstream narratives.
For readers inspired by Cita’s story, the next steps include:
- Following updates on his journey via AFM Téléthon’s official channels or local French media.
- Engaging with disability advocacy groups to amplify voices like Cita’s.
- Exploring adaptive sports programs in your community, such as those listed on the Sport-Santé France website.
As Cita’s journey unfolds, it serves as a powerful reminder that health is not merely the absence of illness but the presence of purpose. In a world where chronic conditions affect millions, his story offers a beacon of hope—and a call to action for greater inclusion.
We invite readers to share their own experiences or those of loved ones navigating chronic illness in the comments below. How has resilience shaped your journey? What barriers have you encountered, and how might stories like Cita’s inspire change? Your voices are invaluable in advancing this conversation.